UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Macrocyclic Dual-Locked “Turn-On” Drug for Selective and Traceless Release in Cancer Cells

Schauenburg, Dominik; Gao, Bingjie; Rochet, Léa NC; Schüler, Darijan; Coelho, Jaime AS; Ng, David YW; Chudasama, Vijay; ... Weil, Tanja; + view all (2024) Macrocyclic Dual-Locked “Turn-On” Drug for Selective and Traceless Release in Cancer Cells. Angewandte Chemie International Edition , Article e202314143. 10.1002/anie.202314143. (In press). Green open access

[thumbnail of Angew Chem Int Ed - 2024 - Schauenburg - Macrocyclic Dual‐Locked  Turn‐On  Drug for Selective and Traceless Release in.pdf]
Preview
Text
Angew Chem Int Ed - 2024 - Schauenburg - Macrocyclic Dual‐Locked Turn‐On Drug for Selective and Traceless Release in.pdf

Download (12MB) | Preview

Abstract

Drug safety and efficacy due to premature release into the bloodstream and poor biodistribution remains a problem despite seminal advances in this area. To circumvent these limitations, we report drug cyclization based on dynamic covalent linkages to devise a dual lock for the small molecule anticancer drug, camptothecin (CPT). Drug activity is "locked" within the cyclic structure by the redox responsive disulfide and pH-responsive boronic acid-salicylhydroxamate and turns on only in the presence of acidic pH, reactive oxygen species and glutathione through traceless release. Notably, the dual-responsive CPT is more active (100-fold) than the non-cleavable (permanently closed) analogue. We further include a bioorthogonal handle in the backbone for functionalization to generate cyclic-locked, cell-targeting peptide- and protein-CPTs, for targeted delivery of the drug and traceless release in triple negative metastatic breast cancer cells to inhibit cell growth at low nanomolar concentrations.

Type: Article
Title: Macrocyclic Dual-Locked “Turn-On” Drug for Selective and Traceless Release in Cancer Cells
Location: Germany
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/anie.202314143
Publisher version: http://dx.doi.org/10.1002/anie.202314143
Language: English
Additional information: Copyright © 2024 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Keywords: drug delivery, dual-responsive chemotherapeutics, macrocyclic drug, traceless release
UCL classification: UCL
UCL > Provost and Vice Provost Offices > UCL BEAMS
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences > Dept of Chemistry
URI: https://discovery.ucl.ac.uk/id/eprint/10185375
Downloads since deposit
12Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item